47 related articles for article (PubMed ID: 7631297)
1. [Peripheral vasodilators: from the hemodynamic effect to clinical benefit].
Chamontin B; Boccalon H
Therapie; 1995; 50(2):89-93. PubMed ID: 7631297
[TBL] [Abstract][Full Text] [Related]
2. Trial of a novel prostacyclin analog, UT-15, in patients with severe intermittent claudication.
Mohler ER; Klugherz B; Goldman R; Kimmel SE; Wade M; Sehgal CM
Vasc Med; 2000; 5(4):231-7. PubMed ID: 11213235
[TBL] [Abstract][Full Text] [Related]
3. [Pentoxifylline and intermittent claudication: critical analysis of clinical trials].
Charansonney OL; Spriet A
Therapie; 1995; 50(1):73-8. PubMed ID: 7754482
[TBL] [Abstract][Full Text] [Related]
4. Pentoxifylline and intermittent claudication: review of clinical trials and cost-effectiveness analyses.
Gillings DB
J Cardiovasc Pharmacol; 1995; 25 Suppl 2():S44-50. PubMed ID: 8699861
[TBL] [Abstract][Full Text] [Related]
5. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
6. [Drug therapy of peripheral arterial occlusive disease].
Mahler F
Schweiz Med Wochenschr; 1981 May; 111(18):637-40. PubMed ID: 7244587
[TBL] [Abstract][Full Text] [Related]
7. Cilostazol: new drug. Intermittent claudication: too little efficacy, too many risks.
Prescrire Int; 2009 Apr; 18(100):56-9. PubMed ID: 19585717
[TBL] [Abstract][Full Text] [Related]
8. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
MMW Fortschr Med; 2002 May; 144(21):54. PubMed ID: 12134429
[No Abstract] [Full Text] [Related]
9. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
Hood SC; Moher D; Barber GG
CMAJ; 1996 Oct; 155(8):1053-9. PubMed ID: 8873633
[TBL] [Abstract][Full Text] [Related]
10. Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDENCE-1).
Jaff MR; Dale RA; Creager MA; Lipicky RJ; Constant J; Campbell LA; Hiatt WR
Circulation; 2009 Jan; 119(3):452-8. PubMed ID: 19139383
[TBL] [Abstract][Full Text] [Related]
11. [Controlled randomized clinical trials].
Jaillon P
Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
[TBL] [Abstract][Full Text] [Related]
12. [Double-blind randomized comparative study of nicergoline naftidrofuryl on the quality of life in chronic obliterative arteriopathy of lower limbs with intermittent claudication].
Meilhac B; Montestruc F; Aubin F; Djian F; Rouffy J
Therapie; 1997; 52(3):179-86. PubMed ID: 9366101
[TBL] [Abstract][Full Text] [Related]
13. [Value of vasoactive drugs in conservative therapy of peripheral arterial occlusive disease].
Scheffler A; Rieger H
Z Arztl Fortbild Qualitatssich; 1999 Nov; 93(9):639-44. PubMed ID: 10666827
[TBL] [Abstract][Full Text] [Related]
14. Rationale for the use of antiplatelet drugs in patients with peripheral vascular disease.
Violi F; Balsano F
Clin Trials Metaanal; 1994 Apr; 29(1):81-7. PubMed ID: 10150187
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological approaches to the treatment of intermittent claudication.
Bevan EG; Waller PC; Ramsay LE
Drugs Aging; 1992; 2(2):125-36. PubMed ID: 1596595
[TBL] [Abstract][Full Text] [Related]
16. Proceedings: The haemodynamic effect of papaverine in peripheral arterial disease.
Quin RO; Evans DH; Bell PR
Br J Surg; 1976 Aug; 63(8):661. PubMed ID: 953493
[No Abstract] [Full Text] [Related]
17. [Effectiveness of long-term treatment with vasodilators in patients with artificial pacemakers].
Xalifa S; Berezov VM
Vrach Delo; 1991 Jun; (6):43-5. PubMed ID: 1891849
[TBL] [Abstract][Full Text] [Related]
18. [Correlations between reactive hyperemia and response to vasodilator agents in patients with obliterating arteriopathies of the lower limbs].
Dabizzi RP; Fantini F; Cappelli G; Grandonico F
Minerva Cardioangiol; 1970 May; 18(5):287-90. PubMed ID: 5515012
[No Abstract] [Full Text] [Related]
19. [Methods for studying vasodilators in man].
Simon A; Gaillot J
J Pharmacol; 1986; 17 Suppl 1():34-40. PubMed ID: 3747538
[No Abstract] [Full Text] [Related]
20. The treatment of peripheral occlusive arterial disease with alpha-tocopherol as compared with vasodilator agents and antiprothrombin (dicumarol).
Haeger K
Vasc Dis; 1968 Dec; 5(4):199-213. PubMed ID: 4177853
[No Abstract] [Full Text] [Related]
[Next] [New Search]
